Mirtazapine-d3 (CAS 1216678-68-0)

Mirtazapine-d3 (CAS 1216678-68-0) References

1. Quantification of antidepressants and antipsychotics in human serum by precipitation and ultra high pressure liquid chromatography-tandem mass spectrometry.  |  Hasselstrøm, J. 2011. J Chromatogr B Analyt Technol Biomed Life Sci. 879: 123-8. PMID: 21163713
2. Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder.  |  Smith, WT., et al. 1990. Psychopharmacol Bull. 26: 191-6. PMID: 2236455
3. Multi-residue analysis of 90 emerging contaminants in liquid and solid environmental matrices by ultra-high-performance liquid chromatography tandem mass spectrometry.  |  Petrie, B., et al. 2016. J Chromatogr A. 1431: 64-78. PMID: 26792447
4. Critical evaluation of monitoring strategy for the multi-residue determination of 90 chiral and achiral micropollutants in effluent wastewater.  |  Petrie, B., et al. 2017. Sci Total Environ. 579: 569-578. PMID: 27876391
5. Multi-residue determination of micropollutants in Phragmites australis from constructed wetlands using microwave assisted extraction and ultra-high-performance liquid chromatography tandem mass spectrometry.  |  Petrie, B., et al. 2017. Anal Chim Acta. 959: 91-101. PMID: 28159109
6. Assessment of simpler calibration models in the development and validation of a fast postmortem multi-analyte LC-QTOF quantitation method in whole blood with simultaneous screening capabilities using SWATH acquisition.  |  Elmiger, MP., et al. 2017. Anal Bioanal Chem. 409: 6495-6508. PMID: 28852820
7. Validation of a fully automated solid-phase extraction and ultra-high-performance liquid chromatography-tandem mass spectrometry method for quantification of 30 pharmaceuticals and metabolites in post-mortem blood and brain samples.  |  Nielsen, MKK., et al. 2018. Drug Test Anal.. PMID: 29341495
8. Multi-residue ultra-performance liquid chromatography coupled with tandem mass spectrometry method for comprehensive multi-class anthropogenic compounds of emerging concern analysis in a catchment-based exposure-driven study.  |  Proctor, K., et al. 2019. Anal Bioanal Chem. 411: 7061-7086. PMID: 31494686
9. Mass spectrometric sample identification with indicator compounds introduced via labeled sample tubes.  |  Paal, M., et al. 2020. Clin Chem Lab Med. 59: 147-154. PMID: 32716904
10. Neurochemical and autonomic pharmacological profiles of the 6-aza-analogue of mianserin, Org 3770 and its enantiomers.  |  de Boer, TH., et al. 1988. Neuropharmacology. 27: 399-408. PMID: 3419539
11. Postmortem Metabolomics: Strategies to Assess Time-Dependent Postmortem Changes of Diazepam, Nordiazepam, Morphine, Codeine, Mirtazapine and Citalopram.  |  Brockbals, L., et al. 2021. Metabolites. 11: PMID: 34564459
12. A new Wastewater-Based Epidemiology workflow to estimate community wide non-communicable disease prevalence using pharmaceutical proxy data.  |  Ceolotto, N., et al. 2024. J Hazard Mater. 461: 132645. PMID: 37793253
13. Trace analysis of 47 psychotropic medications in environmental samples by ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS).  |  Wang, A., et al. 2024. J Chromatogr A. 1715: 464627. PMID: 38171065